Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stem cells for androgenetic alopecia
IRCT20110731007160N11Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in androgenetic alopecia (AGA), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Hair density at 6 months. Started Oct 2025; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20110731007160N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110731007160N11.